Merck sets up new Vioxx review

"Drugmaker Merck has set up an independent committee to review the firm's actions prior to the withdrawal of its painkiller Vioxx from the market in September.

. . .

"Merck has appointed William Bowen, chair of the firm's corporate governance committee, to chair the special committee. " [Guradian UK - Emphasis added]